However, the final analysis did not reach statistical significance regarding overall survival despite remaining clinically relevant with minimal side effects and toxicity in the long-term follow-up ( 17 ).
← all excerpts
Case report: Peptide receptor radioligand therapy in metastatic pediatric neuroendocrine tumors.
1
—
—